102 related articles for article (PubMed ID: 11551762)
1. Potent peptide alpha-ketohydroxamate inhibitors of recombinant human calpain I.
Josef KA; Kauer FW; Bihovsky R
Bioorg Med Chem Lett; 2001 Oct; 11(19):2615-7. PubMed ID: 11551762
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of a series of potent fluoromethyl ketone inhibitors of recombinant human calpain I.
Chatterjee S; Ator MA; Bozyczko-Coyne D; Josef K; Wells G; Tripathy R; Iqbal M; Bihovsky R; Senadhi SE; Mallya S; O'Kane TM; McKenna BA; Siman R; Mallamo JP
J Med Chem; 1997 Nov; 40(23):3820-8. PubMed ID: 9371247
[TBL] [Abstract][Full Text] [Related]
3. Exploration of the importance of the P2-P3-NHCO-moiety in a potent di- or tripeptide inhibitor of calpain I: insights into the development of nonpeptidic inhibitors of calpain I.
Chatterjee S; Iqbal M; Mallya S; Senadhi SE; O'Kane TM; McKenna BA; Bozyczko-Coyne D; Kauer JC; Siman R; Mallamo JP
Bioorg Med Chem; 1998 May; 6(5):509-22. PubMed ID: 9629465
[TBL] [Abstract][Full Text] [Related]
4. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.
Li Z; Patil GS; Golubski ZE; Hori H; Tehrani K; Foreman JE; Eveleth DD; Bartus RT; Powers JC
J Med Chem; 1993 Oct; 36(22):3472-80. PubMed ID: 8230139
[TBL] [Abstract][Full Text] [Related]
5. Novel peptidyl phosphorus derivatives as inhibitors of human calpain I.
Tao M; Bihovsky R; Wells GJ; Mallamo JP
J Med Chem; 1998 Sep; 41(20):3912-6. PubMed ID: 9748367
[TBL] [Abstract][Full Text] [Related]
6. Stereospecific synthesis of peptidyl alpha-keto amides as inhibitors of calpain.
Harbeson SL; Abelleira SM; Akiyama A; Barrett R; Carroll RM; Straub JA; Tkacz JN; Wu C; Musso GF
J Med Chem; 1994 Sep; 37(18):2918-29. PubMed ID: 8071940
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of cinnamoyl ketoamides as hybrid structures of antioxidants and calpain inhibitors.
Yoo YJ; Nam DH; Jung SY; Jang JW; Kim HJ; Jin C; Pae AN; Lee YS
Bioorg Med Chem Lett; 2011 May; 21(10):2850-4. PubMed ID: 21504847
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, molecular modeling studies, and calpain inhibitory activity of novel alpha-ketoamides incorporating polar residues at the P1'-position.
Donkor IO; Han J; Zheng X
J Med Chem; 2004 Jan; 47(1):72-9. PubMed ID: 14695821
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of calpain by peptidyl fluoromethyl ketones.
Angliker H; Anagli J; Shaw E
J Med Chem; 1992 Jan; 35(2):216-20. PubMed ID: 1732539
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of novel calpain inhibitors in preventing renal cell death.
Harriman JF; Waters-Williams S; Chu DL; Powers JC; Schnellmann RG
J Pharmacol Exp Ther; 2000 Sep; 294(3):1083-7. PubMed ID: 10945863
[TBL] [Abstract][Full Text] [Related]
11. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
12. Calpain inhibitors based on the quiescent affinity label concept: high rates of calpain inactivation with leaving groups derived from N-hydroxy peptide coupling reagents.
Tripathy R; Ator MA; Mallamo JP
Bioorg Med Chem Lett; 2000 Oct; 10(20):2315-9. PubMed ID: 11055346
[TBL] [Abstract][Full Text] [Related]
13. A new cell-permeable calpain inhibitor.
Fiorino F; Gil-Parrado S; Assfalg-Machleidt I; Machleidt W; Moroder L
J Pept Sci; 2007 Jan; 13(1):70-3. PubMed ID: 17019744
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological activity of novel peptidyl benzyl ketone FVIIa inhibitors.
Storgaard M; Henriksen ST; Zaragoza F; Peschke B; Tanner D
Bioorg Med Chem Lett; 2011 Jul; 21(13):3918-22. PubMed ID: 21641796
[TBL] [Abstract][Full Text] [Related]
15. Anti-chlamydial activities of cell-permeable hydrophobic dipeptide-containing derivatives.
Itoh R; Soejima T; Hiromatsu K
J Infect Chemother; 2019 Dec; 25(12):987-994. PubMed ID: 31230920
[TBL] [Abstract][Full Text] [Related]
16. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors.
Dragovich PS; Zhou R; Webber SE; Prins TJ; Kwok AK; Okano K; Fuhrman SA; Zalman LS; Maldonado FC; Brown EL; Meador JW; Patick AK; Ford CE; Brothers MA; Binford SL; Matthews DA; Ferre RA; Worland ST
Bioorg Med Chem Lett; 2000 Jan; 10(1):45-8. PubMed ID: 10636240
[TBL] [Abstract][Full Text] [Related]
18. The synthesis of ketomethylene pseudopeptide analogues of dipeptide aldehyde inhibitors of calpain.
Angelastro MR; Marquart AL; Mehdi S; Koehl JR; Vaz RJ; Bey P; Peet NP
Bioorg Med Chem Lett; 1999 Jan; 9(2):139-40. PubMed ID: 10021915
[TBL] [Abstract][Full Text] [Related]
19. Discovery of potent calpain inhibitors based on the azolo-imidazolidenone scaffold.
Gutiérrez S; Morón M; Griera M; Sucunza D; Calleros L; García-Jérez A; Coderch C; Hermoso FJ; Burgos C; Rodríguez-Puyol M; de Pascual-Teresa B; Diez-Marques ML; Jimenez A; Toro-Londoño M; Rodríguez-Puyol D; Vaquero JJ
Eur J Med Chem; 2018 Sep; 157():946-959. PubMed ID: 30165342
[TBL] [Abstract][Full Text] [Related]
20. Affinity labelling of the Ca(2+)-activated neutral proteinase (calpain) in intact human platelets.
Anagli J; Hagmann J; Shaw E
Biochem J; 1993 Jan; 289 ( Pt 1)(Pt 1):93-9. PubMed ID: 8424777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
